全文获取类型
收费全文 | 27637篇 |
免费 | 2128篇 |
国内免费 | 83篇 |
专业分类
耳鼻咽喉 | 210篇 |
儿科学 | 673篇 |
妇产科学 | 612篇 |
基础医学 | 4006篇 |
口腔科学 | 358篇 |
临床医学 | 2824篇 |
内科学 | 5504篇 |
皮肤病学 | 309篇 |
神经病学 | 2550篇 |
特种医学 | 618篇 |
外国民族医学 | 3篇 |
外科学 | 3787篇 |
综合类 | 536篇 |
一般理论 | 42篇 |
预防医学 | 2483篇 |
眼科学 | 887篇 |
药学 | 2289篇 |
中国医学 | 37篇 |
肿瘤学 | 2120篇 |
出版年
2023年 | 188篇 |
2022年 | 265篇 |
2021年 | 610篇 |
2020年 | 384篇 |
2019年 | 619篇 |
2018年 | 620篇 |
2017年 | 482篇 |
2016年 | 582篇 |
2015年 | 680篇 |
2014年 | 960篇 |
2013年 | 1408篇 |
2012年 | 1969篇 |
2011年 | 2082篇 |
2010年 | 1187篇 |
2009年 | 1032篇 |
2008年 | 1721篇 |
2007年 | 1849篇 |
2006年 | 1908篇 |
2005年 | 1898篇 |
2004年 | 1853篇 |
2003年 | 1609篇 |
2002年 | 1498篇 |
2001年 | 230篇 |
2000年 | 183篇 |
1999年 | 251篇 |
1998年 | 340篇 |
1997年 | 288篇 |
1996年 | 269篇 |
1995年 | 253篇 |
1994年 | 202篇 |
1993年 | 212篇 |
1992年 | 151篇 |
1991年 | 126篇 |
1990年 | 107篇 |
1989年 | 98篇 |
1988年 | 106篇 |
1987年 | 93篇 |
1986年 | 83篇 |
1985年 | 91篇 |
1984年 | 101篇 |
1983年 | 102篇 |
1982年 | 132篇 |
1981年 | 124篇 |
1980年 | 95篇 |
1979年 | 54篇 |
1978年 | 60篇 |
1977年 | 64篇 |
1976年 | 58篇 |
1974年 | 55篇 |
1973年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Chaim Kaplinsky Celia Mor Yacov Goshen Isaac Yaniv Hanah Tamary Lutfi Jaber Batia Stark S. Stern Rina Zaizov Ian J. Cohen 《Pediatric hematology and oncology》1992,9(3):261-268
Malignant thymomas are among the least common mediastinal tumors in the pediatric age group. Thymomas are considered malignant on the basis of macroscopic and microscopic invasiveness. As only 20 well-documented cases involving children have been reported in the literature, the pattern of responsiveness to therapy and the value of prognostic signs is obscure. Two cases of malignant pediatric thymomas are reported with pathognomonic histoimmunological features of aggressive thymoma. One was cured, with a follow-up of 70 months, and one died while on therapy. Analysis of the histological features and the immunoperoxidase staining displays the complexity of pediatric thymomas and the inability to prognosticate the outcome, respectively. 相似文献
52.
53.
Patrick P. A. Humphrey Gary Buell Ian Kennedy Baljit S. Khakh Anton D. Michel Annmarie Surprenant Derek J. Trezise 《Naunyn-Schmiedeberg's archives of pharmacology》1995,352(6):585-596
Significant advances in understanding of P2X purinoceptor pharmacology have been made in the last few years. The limitations of nucleotide agonists as drug tools have now been amply demonstrated. Fortunately, inhibitors of the degrading ecto-ATPase enzymes are becoming available and it has become apparent that the complete removal of all divalent cations can be used experimentally in some systems to prevent nucleotide breakdown. Despite these issues, convincing evidence for P2X receptor heterogeneity, from data with agonists, has recently been reported.A number of new antagonists at P2X purinoceptors have also recently been described which to some degree appear to be more specific and useful than earlier antagonists like suramin. It is now apparent that suramin is a poor antagonist of ATP in many tissues because it potently inhibits ATPase activity at similar concentrations to those at which it blocks the P2X purinoceptor.Advances in the use of radiolabelled nucleotides as radioligands for binding studies has allowed the demonstration of P2X purinoceptors in a variety of tissues throughout the body including the brain. These studies have also provided evidence for receptor heterogeneity. Excitingly, two P2X purinoceptor genes have been cloned but operational studies suggest that more than two types exist. The cloning studies have also demonstrated a unique structure for the P2X purinoceptor which differentiates it from all other ligand-gated ion channel receptors. Further studies on P2X purinoceptor operation and structure are needed to help resolve controversies alluded to regarding the characterization and classification of nucleotide receptors. Hopefully such studies will also lead to a better understanding of the physiological and pathological importance of ATP and its activation of P2X purinoceptors. This will require the identification of better drug tools, in particular antagonists which may also provide the basis for novel therapeutic agents. 相似文献
54.
Vijay Tumuluri Graham A. Thomas Ian S. Fraser 《Journal of oral pathology & medicine》2004,33(4):204-208
BACKGROUND: We hypothesise that the density of proliferating cells at the invasive tumour front (ITF) has a positive relationship with prognostic and risk factors in human oral squamous cell carcinoma (SCC). METHODS: Tissues from 47 human oral SCC specimens were collected and stained with a monoclonal antibody directed against the Ki-67 antigen using a horseradish peroxidase based two-step immunostaining method. Counting was performed on two parallel sections at the ITF using an image analyser. The Ki-67 labelling index (LI) was determined by measuring the number of nuclei/mm(2) of epithelium. RESULTS: Our results show that the density of proliferating cells is related to clinical staging, with advanced stage of disease having a significantly higher Ki-67 LI compared with early stage of disease (2111 +/- 905 vs. 1908 +/- 913; P = 0.03). Importantly, this study shows that tumours that have metastasised have a significantly higher Ki-67 LI than tumours where distant metastasis was not detected (3257 +/- 650 vs. 1966 +/- 881; P < 0.0001). CONCLUSIONS: Cell proliferation, as measured by the Ki-67 LI at the ITF, has a positive relationship with clinical staging, tumour thickness, smoking status of the patient and alcohol consumption. Further, we suggest that a multicenter study with a large cohort of patients is indicated to fully elucidate whether cell proliferation at the ITF is directly related to patient survival. 相似文献
55.
56.
Jonathan M Hodgson Kevin D Croft Trevor A Mori Valerie Burke Lawrence J Beilin Ian B Puddey 《The Journal of nutrition》2002,132(1):55-58
Prospective studies suggest that tea may protect against cardiovascular disease. A potential mechanism for such an effect involves inhibition of lipid peroxidation by polyphenolic antioxidants derived from tea. Our objective was to determine whether regular ingestion of tea could inhibit in vivo lipid peroxidation. Two controlled intervention studies assessed the effects of regular ingestion of tea on lipid peroxidation determined by measurement of urinary F(2)-isoprostane excretion. Study 1: The effects of 1000 mL/d of green tea and black tea were compared with hot water containing caffeine in 13 subjects with elevated blood pressure using a randomized 3-period (7 d each) crossover design. Study 2: The effects of 1250 mL/d of black tea were compared with hot water in 22 subjects with mildly raised serum total cholesterol concentrations using a randomized 2-period (4 wk each) crossover design. F(2)-isoprostane excretion was not altered after regular ingestion of green tea (273 +/- 48 pmol/mmol creatinine) or black tea (274 +/- 39 pmol/mmol creatinine) in comparison with hot water (263 +/- 47 pmol/mmol creatinine; Study 1), or by regular ingestion of black tea (334 +/- 71 pmol/mmol creatinine) in comparison with hot water (355 +/- 75 pmol/mmol creatinine; Study 2). These results do not support the suggestion that polyphenolic antioxidants derived from tea inhibit in vivo lipid peroxidation. 相似文献
57.
58.
Ian S Gilfillan 《British medical journal》2003,327(7406):107
59.
60.